These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Epidermal growth factor receptor inhibitors in lung cancer: smaller or larger molecules, selected or unselected populations? Hirsch FR; Bunn PA J Clin Oncol; 2005 Dec; 23(36):9044-7. PubMed ID: 16301593 [No Abstract] [Full Text] [Related]
26. A phase II study of erlotinib monotherapy in pre-treated non-small cell lung cancer without EGFR gene mutation who have never/light smoking history: re-evaluation of EGFR gene status (NEJ006/TCOG0903). Matsumoto Y; Maemondo M; Ishii Y; Okudera K; Demura Y; Takamura K; Kobayashi K; Morikawa N; Gemma A; Ishimoto O; Usui K; Harada M; Miura S; Fujita Y; Sato I; Saijo Y; Lung Cancer; 2014 Nov; 86(2):195-200. PubMed ID: 25249428 [TBL] [Abstract][Full Text] [Related]
27. Response of intracranial metastases to epidermal growth factor receptor tyrosine kinase inhibitors: it may all depend on EGFR mutations. Costa DB; Kobayashi S J Clin Oncol; 2008 Feb; 26(4):686. PubMed ID: 18235134 [No Abstract] [Full Text] [Related]
28. EGFR-TKI rechallenge with bevacizumab in EGFR-mutant non-small cell lung cancer. Otsuka K; Hata A; Takeshita J; Okuda C; Kaji R; Masago K; Fujita S; Katakami N Cancer Chemother Pharmacol; 2015 Oct; 76(4):835-41. PubMed ID: 26349474 [TBL] [Abstract][Full Text] [Related]
34. Evaluation on efficacy and safety of tyrosine kinase inhibitors plus radiotherapy in NSCLC patients with brain metastases. Luo S; Chen L; Chen X; Xie X Oncotarget; 2015 Jun; 6(18):16725-34. PubMed ID: 26057469 [TBL] [Abstract][Full Text] [Related]
35. Safety profiles of erlotinib therapy in patients with advanced non-small-cell lung cancer. Hotta K; Kiura K Expert Rev Anticancer Ther; 2011 Jul; 11(7):991-7. PubMed ID: 21806322 [TBL] [Abstract][Full Text] [Related]
36. A prospective, multicentre phase II trial of low-dose erlotinib in non-small cell lung cancer patients with EGFR mutations pretreated with chemotherapy: Thoracic Oncology Research Group 0911. Yamada K; Aono H; Hosomi Y; Okamoto H; Kato T; Komase Y; Nishikawa M; Azuma K; Takeoka H; Okuma Y; Nakahara Y; Sato A; Oba MS; Morita S; Kunitoh H; Watanabe K Eur J Cancer; 2015 Sep; 51(14):1904-10. PubMed ID: 26174465 [TBL] [Abstract][Full Text] [Related]
37. Disseminated herpes simplex virus infection following epidermal growth factor tyrosine kinase inhibitor therapy for non-small-cell lung carcinoma. Teh BW; Worth LJ Intern Med J; 2012 Nov; 42(11):1269-70. PubMed ID: 23157525 [No Abstract] [Full Text] [Related]